708 related articles for article (PubMed ID: 18682947)
21. Role of thrombotic risk factors in end-stage renal disease.
Tripathi G; Sankhwar SN; Sharma RK; Baburaj VP; Agrawal S
Clin Appl Thromb Hemost; 2010 Apr; 16(2):132-40. PubMed ID: 19520684
[TBL] [Abstract][Full Text] [Related]
22. PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.
Pourgheysari B; Boroujeni HR; Hasheminia AM; Drees F
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):471-6. PubMed ID: 23358226
[TBL] [Abstract][Full Text] [Related]
23. Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma.
Pihusch R; Danzl G; Scholz M; Harich D; Pihusch M; Lohse P; Hiller E
Cancer; 2002 Jun; 94(12):3120-6. PubMed ID: 12115343
[TBL] [Abstract][Full Text] [Related]
24. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
25. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
[TBL] [Abstract][Full Text] [Related]
26. No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study.
Meyer M; Laux G; Scherer S; Tran TH; Opelz G; Mytilineos J
Transplantation; 2007 Apr; 83(8):1055-8. PubMed ID: 17452895
[TBL] [Abstract][Full Text] [Related]
27. Thrombophilia-related genetic variations in patients with pulmonary embolism in the main teaching hospital in Jordan.
Obeidat NM; Awidi A; Sulaiman NA; Abu-Khader IB
Saudi Med J; 2009 Jul; 30(7):921-5. PubMed ID: 19618008
[TBL] [Abstract][Full Text] [Related]
28. Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer.
Cam R; Eroglu A; Egin Y; Akar N
Breast Cancer Res Treat; 2009 May; 115(2):431-2. PubMed ID: 18498051
[No Abstract] [Full Text] [Related]
29. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
[TBL] [Abstract][Full Text] [Related]
30. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
[TBL] [Abstract][Full Text] [Related]
31. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
Ben Salem-Berrabah O; Fekih-Mrissa N; N'siri B; Ben Hamida A; Benammar-Elgaaied A; Gritli N; Mrissa R
J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
[TBL] [Abstract][Full Text] [Related]
32. Genetic and acquired prothrombotic risk factors and sudden hearing loss.
Capaccio P; Ottaviani F; Cuccarini V; Bottero A; Schindler A; Cesana BM; Censuales S; Pignataro L
Laryngoscope; 2007 Mar; 117(3):547-51. PubMed ID: 17334320
[TBL] [Abstract][Full Text] [Related]
33. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
[TBL] [Abstract][Full Text] [Related]
34. Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.
Törüner M; Erkan O; Soykan I; Bozdayi M; Cetinkaya H; Yurdaydin C; Uzunalimoğlu O; Ozden A
Turk J Gastroenterol; 2004 Dec; 15(4):250-2. PubMed ID: 16249980
[TBL] [Abstract][Full Text] [Related]
35. [Risk of thrombophilia in carriers of thrombophilic genetic factors in unsuccessful assisted reproduction].
Ivanov P; Komsa-Penkova R; Kovacheva K; Konova E; Todorova K; Simeonova M; Ivanov I; Stoĭkov S; Popov I; Tanchev S; Bozhinova S
Akush Ginekol (Sofiia); 2007; 46(6):3-8. PubMed ID: 17974163
[TBL] [Abstract][Full Text] [Related]
36. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
37. Thrombophilic gene polymorphisms in puerperal cerebral veno-sinus thrombosis.
Dindagur N; Kruthika-Vinod TP; Christopher R
J Neurol Sci; 2006 Nov; 249(1):25-30. PubMed ID: 16839569
[TBL] [Abstract][Full Text] [Related]
38. MTHFR C677T, FII G20210A, FV Leiden G1691A, NOS3 intron 4 VNTR, and APOE epsilon4 gene polymorphisms are not associated with spontaneous cervical artery dissection.
Jara-Prado A; Alonso ME; Martínez Ruano L; Guerrero Camacho J; Leyva A; López M; Gutierrez-Castrellon P; Arauz A
Int J Stroke; 2010 Apr; 5(2):80-5. PubMed ID: 20446941
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
[TBL] [Abstract][Full Text] [Related]
40. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.
Fawaz NA; Bashawery L; Al-Sheikh I; Qatari A; Al-Othman SS; Almawi WY
Am J Hematol; 2004 Jul; 76(3):307-9. PubMed ID: 15224376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
